Bleeding Disorders
From the Journals
Prophylaxis maintains high FIX trough levels in hemophilia B
Sustaining high FIX trough levels may successfully change a case of severe disease into a mild bleeding phenotype.
From the Journals
Hemophilia questionnaire proves valid around the globe
The questionnaire, that focused on patient-reported outcomes, has little variability based on region of the world.
From the Journals
Emicizumab may improve thrombosis management in hemophilia A
The case report offers real-world insights into treatment using emicizumab.
Commentary
A new era of TTP treatment
Many questions remain following the FDA’s approval of caplacizumab, specifically, which patients should receive it. The high cost of the drug is...
From the Journals
Weekly turoctocog alfa pegol is feasible for hemophilia A
An extension of the pathfinder 2 trial produced encouraging results with providing a stepped-down regimen in severe hemophilia A patients.
From the Journals
Bleeding disorders don’t carry increased risks for patients undergoing endoscopy
Findings from a retrospective study of 48 patients with bleeding disorders suggests that there is not a greater risk of bleeding when undergoing...
From the Journals
Erectile dysfunction appears prevalent with hemophilia
A survey of men with hemophilia reveals that erectile dysfunction may be fairly common with the bleeding disorder and that its prevalence...
From the Journals
FXIII replacement may improve hemostasis in acquired hemophilia A
The researchers found that measuring Factor XIII levels was useful in helping control hemostasis.
From the Journals
Von Willebrand disease screening is low prior to hysterectomy
The level of screening – less than 1% – is out of alignment with current recommendations that call for consideration of underlying bleeding...